Results 181 to 190 of about 850,186 (307)

Steric Hindrance and Secondary Interactions Govern Reconfiguration Between Two Complex CuI Coordination Cages

open access: yesAngewandte Chemie, EarlyView.
Fine‐tuning steric and C─H···π contacts directs assembly of two CuI cages. An identical naphthylene‐based subcomponent forms a [CuI12L6]12+ pseudo‐hexagonal prism stabilized by 29–32 C─H···π contacts and 12 arene stacking pairs with 6‐methyl‐2‐formylpyridine, whereas the 3‐methyl analog imparts steric clashes, yielding a [CuI8L4]8+ open prism ...
Houyang Xu   +3 more
wiley   +2 more sources

RaPID Selection of Backbone Macrocyclic Peptides Targeting Akt2

open access: yesAngewandte Chemie, EarlyView.
Backbone macrocyclic peptide library (BMP) library was screened against Akt2 via RaPID to discover potent BMPPakti‐3 (IC50 = 34 nM). ABSTRACT Backbone‐cyclic peptides (BMPs) are an attractive class of molecules appeared in diverse natural bioactive products. However, mRNA display technology coupled with ribosomal synthesis is intrinsically inapplicable
Koki Shinbara   +4 more
wiley   +2 more sources

Trion quantum coherence in site-controlled pyramidal InGaAs quantum dots. [PDF]

open access: yesSci Rep
Barcan RA   +5 more
europepmc   +1 more source

Hematoma Interleukin‐1 Receptor Antagonist Concentrations Predict Long‐Term Outcome in Acute Human Intracerebral Hemorrhage

open access: yesAnnals of Neurology, EarlyView.
Objectives The interleukin (IL)‐1, IL‐6, and C‐reactive protein (CRP) pathway is central to the immune response after intracerebral hemorrhage (ICH). We tested for associations between hematoma and plasma cytokine concentrations and patient outcomes in Minimally Invasive Surgery Plus Rt‐PA for ICH Evacuation Phase III (MISTIE III) participants ...
Adrian R. Parry‐Jones   +54 more
wiley   +1 more source

Nonviral Gold Nanoparticle‐Mediated Delivery of CRISPR‐Cas9 Ribonucleoprotein and Long DNA Transgenes Into Primary Blood Cells

open access: yesAdvanced NanoBiomed Research, EarlyView.
CRISPR/Cas9 has revolutionized the field of gene therapy, but delivery remains an outstanding issue. We propose a nonviral gold‐nanoparticle platform for co‐delivery of CRISPR/Cas9 ribonucleoprotein and long 2.1 kilobase dsDNA transgene constructs. This CRISPR‐AuNP is inexpensive to produce and mediate gene editing and DNA delivery in T cells and CD34+
Rachel A. Cunningham   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy